Equate One-Step Medicated Corn Removers

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of corns. It provides relief from pain associated with corns through its effective removal action.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The affected area should be washed, and it is recommended to soak the corn in warm water for approximately 5 minutes. After soaking, the area must be dried thoroughly to ensure proper adhesion of the medicated patch.

To apply the medicated patch, healthcare professionals should remove the bandage strips by peeling the backing off. The patch should then be adhered directly over the corn. This procedure may be repeated every 48 hours as needed, continuing until the corn is removed, for a maximum duration of 14 days.

Contraindications

There are no specific contraindications identified for this product. However, it is essential to adhere to the following precautions:

Keep out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately. If discomfort persists, discontinue use and consult a healthcare professional.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a physician prior to use if they have a history of diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects.

Patients are instructed to discontinue use and seek medical advice if discomfort persists. It is essential to monitor for any signs of prolonged irritation or adverse reactions.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay. Prompt action is critical to ensure patient safety in such situations.

Side Effects

For external use only. Patients are advised to consult a doctor prior to use if they have diabetes or poor blood circulation. In the event that discomfort persists, it is recommended to discontinue use and seek medical advice.

Additionally, it is crucial to keep this product out of reach of children. If swallowed, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Equate One-Step Medicated Corn Removers (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is currently no information available regarding the use of Equate One-Step Medicated Corn Removers during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering this product for pregnant patients. Healthcare professionals should exercise caution and consider the absence of data when advising women of childbearing potential regarding the use of this product during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of the drug in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of poison control and emergency medical services is recommended to ensure optimal patient care and safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important for patients to understand the significance of this action to ensure their safety.

Patients should be instructed to discontinue use and consult a doctor if they experience persistent discomfort. This guidance is crucial for monitoring their condition and preventing potential complications.

Additionally, healthcare providers should encourage patients to consult with a doctor prior to using the product if they have diabetes. This precaution is necessary to avoid any adverse effects related to their underlying health condition.

Furthermore, patients with poor blood circulation should also be advised to seek medical advice before using the product. This step is essential to ensure that their specific health needs are addressed appropriately.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within a temperature range of 59° to 86°F (15° to 30°C) to maintain its integrity and efficacy. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable container that protects it from environmental factors. Special handling requirements should be followed to prevent any compromise to the product's quality.

Additional Clinical Information

The product is administered topically, with the recommended procedure to be repeated every 48 hours as needed until the corn is removed, for a maximum duration of 14 days. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Equate One-Step Medicated Corn Removers, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)